Pharmaengine, Inc.

Taipei, TW· latest recorded location

PHARMAENGINE, INC. is named on 1 US grants and 3 published applications in this corpus. Its most frequent classification is C07D (Heterocyclic compounds).

Granted patents: 1
Published applications: 3
Inventors: 9
Granted in 2026 so far: 0
Most recent grant: 14 Sep 2021

Filings by year

Pharmaengine, Inc.: granted patents and published applications per publication year
Year	Granted patents	Published applications
2021	1	1
2022	0	0
2023	0	0
2024	0	2

By publication year.

Technology areas

Share of 4 documents

C07DHeterocyclic compounds4
A61KMedicines and medical preparations3
A61PTherapeutic uses of medicines3
C07BGeneral methods of organic chemistry1
C07CAcyclic or carbocyclic compounds1

Recent patents

3,5-disubstituted pyrazoles useful as checkpoint kinase 1 (Chk1) inhibitors, and their preparations and applications14 Sep 2021US 11,116,767 B2

All 1 patents

Most cited

By later US patents

None of its patents has been cited by a later US patent yet.